Roche tops pharmaceutical ranking for future viability of companies
Published: Tuesday, Nov 26th 2024, 01:10
Updated At: Tuesday, Nov 26th 2024, 00:59
العودة إلى البث المباشر
The Swiss pharmaceutical company Roche has achieved the top position in a ranking by the IMD Business School in Lausanne on the future readiness of pharmaceutical companies. According to the "Future Readiness Indicator 2024" published on Tuesday, Roche achieved the maximum score of 100.
Novo Nordisk, Eli Lilly, AstraZeneca and the Swiss company Novartis follow in the next places. The study evaluates factors such as research and development, financial strength and innovation pipeline.
According to the analysis, the top performers are characterized by excellent research, financial discipline and a strong product pipeline. They are also increasingly relying on artificial intelligence in drug development. According to the study, global pharmaceutical companies invest a total of over 200 billion dollars in research and development.
Richemont seventh in the luxury segment
In the fashion and luxury sector, the luxury companies Hermès and Moët Hennessy Louis Vuitton (LVMH) lead the ranking, followed by Inditex (known for Zara), Nike and Lululemon. The Swiss luxury goods group Richemont (known for Cartier, Van Cleef & Arpels, IWC Schaffhausen) took seventh place, dropping one place compared to the previous year. The Swatch Group even slipped six places to 28th place.
In particular, the analysis underlines the importance of operational agility and considered geographical expansion in the luxury goods sector. The slowdown in Chinese economic growth is likely to be relevant for the Swiss luxury goods industry - the study forecasts GDP growth of just 4.5 percent in China by 2025.
AI as a challenge
In the technology sector, the IMD study shows the increasing importance of AI capabilities. While US companies such as Nvidia, Microsoft and Meta occupy the top positions, Taiwanese chip manufacturer TSMC plays an important role as a supplier. According to the study, Swiss technology providers are also increasingly having to adapt to geopolitical tensions and the battle for AI infrastructures.
Increasing geopolitical tensions, the integration of AI and the balance between innovation and sustainable development are cited as challenges for industry leaders in all three economic sectors.
©كيستون/إسدا
Arabic 
English 
German 
French 
Spanish